Preveceutical Medical Inc PRVCF

Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc > PREV Files Prov Patent Application for D-Amino Acid Peptides

<< Previous

Bullboard Posts

Next >>

Comment by Walter333on Nov 24, 2021 7:57pm

121 Views

Post# 34163750

RE:PREV Files Prov Patent Application for D-Amino Acid Peptides

That's some great news, keep it up and keep it coming! Looking forward to some trials to prove some of this technology. Retail fomo, and some bad egg CEOs of certain companies taking advantage in the cannabis sector put a damper on things along with the pandemic, feel some successful trials be it by Preveceutical or other companies within the sector are necessary, much needed in order to bring some credibility back to the sector. Things are coming together, news will start to show that.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”